| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 9.002.447 $ | 99,20 | 79.409 | ||||||
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 712.168 $ | 7,85 | 2.838 | |
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 704.239 $ | 7,76 | 613 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 530.846 $ | 5,85 | 1.281 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 437.342 $ | 4,82 | 3.359 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 437.333 $ | 4,82 | 1.706 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 341.411 $ | 3,76 | 2.007 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 338.837 $ | 3,73 | 590 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 324.068 $ | 3,57 | 4.962 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 282.113 $ | 3,11 | 2.669 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 256.689 $ | 2,83 | 2.458 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 256.136 $ | 2,82 | 586 | |
| Novo Nordisk A/S | Novo Nordisk A/S, Class B | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 237.170 $ | 2,61 | 5.014 | |
| GSK plc | GSK plc | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 223.755 $ | 2,47 | 8.605 | |
| Stryker Corp. | Stryker Corp. | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 201.934 $ | 2,23 | 620 | |
| Danaher Corp. | Danaher Corp. | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 196.150 $ | 2,16 | 1.006 | |
| Cencora, Inc. | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 188.049 $ | 2,07 | 604 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 214.124 $ | 2,36 | 250 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 175.252 $ | 1,93 | 496 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 157.250 $ | 1,73 | 1.827 | |
| IQVIA Holdings, Inc. | IQVIA Holdings, Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 155.348 $ | 1,71 | 661 | |
| Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Ltd. | EC | IL0006290147 | Long | Modellwert (Stufe 2) | 145.306 $ | 1,60 | 4.084 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 144.900 $ | 1,60 | 190 | |
| Novartis AG | Novartis AG (Registered) | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 144.819 $ | 1,60 | 926 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 141.862 $ | 1,56 | 699 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 137.328 $ | 1,51 | 597 | |
| Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical Co. Ltd. | EC | JP3463000004 | Long | Modellwert (Stufe 2) | 116.741 $ | 1,29 | 3.400 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 108.263 $ | 1,19 | 1.740 | |
| Hoya Corp. | Hoya Corp. | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 107.042 $ | 1,18 | 700 | |
| Humana, Inc. | Humana, Inc. | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 105.519 $ | 1,16 | 290 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 96.684 $ | 1,07 | 2.069 | |
| Fresenius SE & Co. KGaA | Fresenius SE & Co. KGaA | EC | DE0005785604 | Long | Modellwert (Stufe 2) | 94.108 $ | 1,04 | 1.831 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 88.148 $ | 0,97 | 894 | |
| Genmab A/S | Genmab A/S | EC | DK0010272202 | Long | Modellwert (Stufe 2) | 75.702 $ | 0,83 | 263 | |
| Sartorius AG | Sartorius AG (Preference) | EC | DE0007165631 | Long | Modellwert (Stufe 2) | 75.106 $ | 0,83 | 298 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 74.734 $ | 0,82 | 2.968 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 73.951 $ | 0,81 | 155 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 69.814 $ | 0,77 | 710 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 66.553 $ | 0,73 | 399 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 65.834 $ | 0,73 | 822 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 63.917 $ | 0,70 | 311 | |
| Align Technology, Inc. | Align Technology, Inc. | EC | 016255101 | Long | Börsenkurs (Stufe 1) | 63.604 $ | 0,70 | 376 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 60.220 $ | 0,66 | 259 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 56.311 $ | 0,62 | 791 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 53.172 $ | 0,59 | 218 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 51.811 $ | 0,57 | 1.834 | |
| LB Pharmaceuticals, Inc. | LB Pharmaceuticals, Inc. | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 50.421 $ | 0,56 | 1.258 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 46.200 $ | 0,51 | 600 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 44.751 $ | 0,49 | 658 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 40.216 $ | 0,44 | 1.484 | |
| Arcus Biosciences, Inc. | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 39.015 $ | 0,43 | 1.384 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 35.501 $ | 0,39 | 1.956 | |
| Damora Therapeutics, Inc. | Damora Therapeutics, Inc. | EC | KYG2646Y1044 | Long | Börsenkurs (Stufe 1) | 33.802 $ | 0,37 | 1.166 | |
| Medtronic plc | Medtronic plc | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 31.338 $ | 0,35 | 367 | |
| Legend Biotech Corp. | Legend Biotech Corp. | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 28.548 $ | 0,31 | 1.539 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 990 $ | 0,01 | 21 | |
| Gesamt | 9.002.447 $ | 99,20 | 79.409 |